ロード中...
The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma
BACKGROUND: Mantle cell lymphoma (MCL) is an incurable B cell-derived malignant tumor with a median overall survival of 4–5 years. Mer tyrosine kinase (MerTK) has been reported to be aberrantly expressed in leukemia, melanoma, and gastric cancer, and plays a pivotal role in the process of oncogenesi...
保存先:
| 出版年: | J Hematol Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5859520/ https://ncbi.nlm.nih.gov/pubmed/29554921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0584-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|